Impact of Actinic Keratosis (AK), as measured by patient-reported AK symptoms, and impact on emotions and functioning (using Skindex-16) among patients with AK administered tirbanibulin in real-world community practices across the U.S. (PROAK Study). J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Oct. 2];7(2):s161. Available from: https://skin.dermsquared.com/skin/article/view/2047